Table 5 Correlations between increases in FMD or Ln-RHI and the clinical variables in the abstainers, adjusted for age and sex (n = 58)

From: Predictors of the effects of smoking cessation on the endothelial function of conduit and digital vessels

Variables

Increase in FMD

Increase in Ln-RHI

OR (95% CI)

p value

OR (95% CI)

p value

Age (baseline)

1.05 (0.99–1.10)

0.086

1.00 (0.96–1.06)

0.884

Female

2.55 (0.69–9.45)

0.161

3.06 (0.83–11.3)

0.093

Brinkman index

0.99 (0.99–1.00)

0.043*

1.00 (0.99–1.00)

0.329

CO (baseline)

1.00 (0.94–1.08)

0.903

0.98 (0.91–1.05)

0.523

BMI (baseline)

1.12 (0.96–1.31)

0.159

0.83 (0.71–0.99)

0.032*

Waist circumference (baseline)

1.05 (0.98–1.11)

0.152

0.96 (0.90–1.02)

0.160

Hypertension

0.44 (0.13–1.52)

0.193

1.09 (0.33–3.57)

0.890

Diabetes mellitus

0.95 (0.18–5.11)

0.951

1.17 (0.23–6.11)

0.850

Dyslipidemia

2.05 (0.57–7.41)

0.272

0.35 (0.08–1.47)

0.151

Previous CAD

0.70 (0.13–3.67)

0.672

0.97 (0.19–5.13)

0.975

Baseline diameter (baseline)

1.40 (0.49–3.96)

0.528

1.31 (0.47–3.70)

0.605

FMD (baseline)

0.73 (0.55–0.97)

0.030*

1.02 (0.78–1.33)

0.909

baIMT (baseline)

1.64 (0.67–4.02)

0.280

0.56 (0.24–1.33)

0.190

Ln-RHI (baseline)

0.48 (0.06–3.78)

0.487

0.01 (0.00–0.16)

0.001*

CO change

1.00 (0.93–1.07)

0.993

1.02 (0.96–1.10)

0.508

BMI change

1.09 (0.54–2.18)

0.814

1.45 (0.71–2.98)

0.310

Waist circumference change

0.98 (0.87–1.11)

0.762

0.98 (0.86–1.11)

0.745

SBP change

0.94 (0.89–0.99)

0.040*

1.06 (1.00–1.13)

0.047*

DBP change

0.95 (0.88–1.03)

0.198

1.05 (0.97–1.14)

0.204

HR change

1.01 (0.95–1.08)

0.744

1.00 (0.94–1.06)

0.899

Fasting glucose change

0.99 (0.95–1.04)

0.701

1.02 (0.97–1.07)

0.395

HbA1c change

0.33 (0.06–1.75)

0.191

0.49 (0.10–2.34)

0.373

HOMA-R change

1.64 (0.82–3.26)

0.159

1.05 (0.59–1.85)

0.882

Total cholesterol change

0.99 (0.96–1.01)

0.295

1.02 (1.00–1.05)

0.060

HDL-C change

0.95 (0.89–1.01)

0.116

1.07 (1.00–1.16)

0.059

LDL-C change

1.00 (0.99–1.02)

0.676

1.01 (0.99–1.03)

0.442

Triglycerides change

1.00 (0.99–1.01)

0.563

1.00 (1.00–1.01)

0.327

Varenicline

1.00 (0.31–3.22)

1.000

0.61 (0.18–2.03)

0.419

Nicotine patch

0.89 (0.23–3.53)

0.871

1.20 (0.30–4.86)

0.795

No pharmacotherapy

0.85 (0.23–6.02)

0.850

2.10 (0.36–12.4)

0.431

  1. In the multivariate logistic regression analysis, each clinical variable was adjusted for age and sex
  2. Abbreviations as in Table 1
  3. *p < 0.05
Back to article page